Skip to main content

Table 1 Clinicopathologic features of the 122 patients with PDAC

From: Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma

Parameters

Patients with PDAC (n = 122)

Median age (range)

69 (43–90)

Sex

 Male/female

65/57

Tumor location

 Head/body and tail

71/51

Differentiation grade

 G1/G2/G3/G4

54/52/15/1

TNM stage

 I/II/III/IV

48/50/19/5

Tumor size

 pT1/pT2/pT3/pT4

24/80/18/0

Microvascular invasion

 Positive/negative/unknown

106/14/2

Lymphatic permeation

 Positive/negative

90/32

Perineural invasion

 Positive/negative

102/20

Nodal metastasis

 pN0/pN1/pN2

49/52/21

Neoadjuvant chemotherapy

 Yes/no

65/57

Adjuvant chemotherapy

 Yes/no/unknown

106/12/4

Postoperative radiotherapy

 Yes/no

7/115

  1. PDAC pancreatic ductal adenocarcinoma, G1 well-differentiated carcinoma, G2 moderately differentiated carcinoma, G3 poorly differentiated carcinoma, G4 undifferentiated carcinoma